FDA Adverse Event Other Summary report: N

VERSANT 440 HCV RNA 3.0 ASSAY (BDNA)

MDR report key: 3234085 · Received July 16, 2013

Report

Report Number
3003932969-2013-00003
Event Type
Other
Date Received
July 16, 2013
Date of Event
June 25, 2013
Report Date
July 12, 2013
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS
Product Code
MZP
PMA / PMN Number
P020022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

FOR MEDICAL DEVICE REPORTING PURPOSES THIS EVENT IS CONSIDERED CLOSED.

Description of Event or Problem · 1

USING THE VERSANT HCV RNA 3.0 ASSAY (BDNA), TWO PT SAMPLES GAVE (B)(6) RESULTS. THESE VALUES WERE NOT REPORTED. THE RUNS WERE REPEATED AND THE RESULTS WERE (B)(6). THE ASSAY IS INTENDED AS AN AID IN THE MGMT OF (B)(6) PTS UNDERGOING ANTI-VIRAL THERAPY. NO CHANGE OF THERAPY OCCURRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
328793 VERSANT 440 HCV RNA 3.0 ASSAY (BDNA) VERSANT 440 HCV RNA 3.0 ASSAY (BDNA) MZP SIEMENS HEALTHCARE DIAGNOSTICS C047

Patients

Seq Age Sex Outcome Treatment
1 Other